Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Molecular imaging and the neuropathologies of Parkinson's disease

Cumming P, Borghammer P.

Curr Top Behav Neurosci. 2012;11:117-48. doi: 10.1007/7854_2011_165.

A phaeochromocytoma occurring in a patient with Parkinson's disease on L-dopa therapy: a diagnostic challenge

Collier A, Ghosh S, Breckenridge A, Perry CG, Freel EM, Davidson DF.

Clin Endocrinol (Oxf). 2012 May;76(5):763-4. doi: 10.1111/j.1365-2265.2011.04266.x.

Psychometric properties of the Starkstein Apathy Scale in patients with early untreated Parkinson disease

Pedersen KF, Alves G, Larsen JP, Tysnes OB, Møller SG, Brønnick K.

Am J Geriatr Psychiatry. 2012 Feb;20(2):142-8. doi: 10.1097/JGP.0b013e31823038f2.

GPE and GPE analogues as promising neuroprotective agents

Cacciatore I, Cornacchia C, Baldassarre L, Fornasari E, Mollica A, Stefanucci A, Pinnen F.

Mini Rev Med Chem. 2012 Jan;12(1):13-23. doi: 10.2174/138955712798868995.

The neuropathology, pathophysiology and genetics of multiple system atrophy

Ahmed Z, Asi YT, Sailer A, Lees AJ, Houlden H, Revesz T, Holton JL.

Neuropathol Appl Neurobiol. 2012 Feb;38(1):4-24. doi: 10.1111/j.1365-2990.2011.01234.x.

Complexity of motor response to different doses of duodenal levodopa infusion in Parkinson disease

Nyholm D, Johansson A, Aquilonius SM, Hellquist E, Lennernäs H, Askmark H.

Clin Neuropharmacol. 2012 Jan-Feb;35(1):6-14. doi: 10.1097/WNF.0b013e31823b1ffd.

Vitamin C transport and its role in the central nervous system

May JM.

Subcell Biochem. 2012;56:85-103. doi: 10.1007/978-94-007-2199-9_6.

Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies

Lu M, Hu G.

Clin Exp Pharmacol Physiol. 2012 Jun;39(6):577-85. doi: 10.1111/j.1440-1681.2011.05650.x.

Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice

Moriguchi S, Yabuki Y, Fukunaga K.

J Neurochem. 2012 Feb;120(4):541-51. doi: 10.1111/j.1471-4159.2011.07608.x. Epub 2012 Jan 6.

Clinical utility of screening for clinical depression and bipolar disorder

Mitchell AJ.

Curr Opin Psychiatry. 2012 Jan;25(1):24-31. doi: 10.1097/YCO.0b013e32834de45b.

Flexibility of Markov modeling for clinical pharmacoeconomics: illustration for cost-effectiveness in early Parkinson's disease

Postma MJ, Boersma C.

Expert Rev Clin Pharmacol. 2012 Jan;5(1):1-4. doi: 10.1586/ecp.11.69.

Advances in the laboratory evaluation of peripheral neuropathies

Huan MC, Bromberg M.

Curr Neurol Neurosci Rep. 2012 Feb;12(1):84-91. doi: 10.1007/s11910-011-0239-2.

Istradefylline for the treatment of Parkinson's disease

Park A, Stacy M.

Expert Opin Pharmacother. 2012 Jan;13(1):111-4. doi: 10.1517/14656566.2012.643869.

The effects of visual and auditory cues on freezing of gait in patients with Parkinson disease

Lee SJ, Yoo JY, Ryu JS, Park HK, Chung SJ.

Am J Phys Med Rehabil. 2012 Jan;91(1):2-11. doi: 10.1097/PHM.0b013e31823c7507.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias